フォスフォウビキチン誘発のPARKIN活性化のメカニズム
Tobias Wauer1, Michal Simicek1, Alexander Schubert1
1Medical Research Council Laboratory of Molecular Biology, Francis Crick Avenue, Cambridge CB2 0QH, UK.
Nature
|July 11, 2015
まとめ
リン酸化ユビキチンに結合したPARKINの結晶構造は,変異がパーキンソン病を引き起こす方法を明らかにします. この発見は,PARKINの活性化を説明し,この疾患の新たな治療目標を示唆しています.
科学分野:
- バイオケミストリー バイオケミストリー
- 構造生物学 構造生物学とは
- 神経科学は神経科学である.
背景:
- PARKIN (PARK2) とPINK1 (PARK6) の突然変異は,オートソームリセッシブジュベナルパーキンソン病 (AR-JP) を引き起こします.
- PARKINとPINK1は,損傷したミトコンドリアを除去するためにミトファジーで協力します.
- PINK1はユビキチンとPARKIN Ublドメインをリン酸化し,脱極化ミトコンドリアにPARKINを徴募および活性化します.
研究 の 目的:
- 酸化ユビキチンによるPARKINの徴募と活性化の分子メカニズムを解明する.
- AR-JPに関連した変異が PARKIN 機能にどのように影響するかを理解するために.
主な方法:
- ペディクルス・ヒューマナス・パーキン (Pediculus humanus PARKIN) のX線結晶図で,Ser65-phosphorylated ubiquitin (phosphoUb) と複合されている.
主要な成果:
- 結晶構造は,PhosphoUbがPARKIN上の保存されたリン酸ポケットに結合することを明らかにし,採用と活性化を説明します.
- PhosphoUb結合は構造変化を誘導し,抑制的なUblドメインを解放し,PARKINを活性化します.
- このUblの放出は,PINK1によるUblのさらなるリン酸化を促進し,アクティブなPARKIN構成を安定させます.
結論:
- Ublドメインは,phosphoUb.Ub.によって放出される抑制された活性化要素として作用します.
- この研究では,PARKINの活性化とパーキンソン病におけるその役割の構造的基礎を明らかにしています.
- 小分子PARKIN活性化剤の開発のための潜在的な戦略を特定します.
関連する概念動画
Covalently Linked Protein Regulators
9.9K
Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein....
These groups modify specific amino acids in a protein....
9.9K
Regulated Protein Degradation
9.3K
It is vital to regulate the activity of enzymatic as well as non-enzymatic proteins inside the cell. This can be achieved either through creating a balance between their rate of synthesis and degradation or regulating the intrinsic activity of the protein. Both these regulation mechanisms play an essential role in the normal functioning of cells.
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
9.3K
PI3K/mTOR/AKT Signaling Pathway
6.4K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
6.4K
Protein Kinases and Phosphatases
15.7K
Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
15.7K
The Proteasome
2.0K
Eukaryotic cells can degrade proteins through several pathways. One of the most important among these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
2.0K
The Proteasome
10.6K
Eukaryotic cells can degrade proteins through several pathways. One of the most important amongst these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
10.6K


